About Daicel
Daicel is a company based in Minato (Japan) founded in 1919. Daicel has completed 3 acquisitions, including Arbor Biosciences, Lomapharm and Special Devices.
- Headquarter Minato, Japan
-
Sectors
Chemicals & Materials
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Daicel Safety Systems India Private Limited
- Date of Incorporation 30 Oct, 2018
- Jurisdiction Chengalpattu, Tamil Nadu, India
-
Annual Revenue
$3.93 B (USD)5.1as on Mar 31, 2025
-
Net Profit
$331.12 M (USD)-11.38as on Mar 31, 2025
-
EBITDA
$685.13 M (USD)6.54as on Mar 31, 2025
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
-
Investments & Acquisitions
Arbor Biosciences
& 2 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Daicel
Unlock access to complete
Funding Insights of Daicel
Detailed funding history for Daicel
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Daicel
Daicel has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Arbor Biosciences, Lomapharm and Special Devices.
Investment portfolio details for Daicel
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
DNA analysis microarrays are provided by Arbor Biosciences.
|
Locked | Locked | 2006 | Locked | |
|
Advanced sunglasses and eyeglasses are manufactured with proprietary lens technologies.
|
Locked | Locked | 1976 | Locked | |
|
Pharmaceutical drugs are manufactured by Lomapharm in Germany since 1878.
|
Locked | Locked | 1878 | Locked |
Complete acquisition details for Daicel
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Daicel
Detailed financials for Daicel
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Daicel Comparisons
Peer comparison for Daicel
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Daicel
Detailed competitors of Daicel
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Daicel
Complete news archive for Daicel
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Daicel
Daicel was founded in 1919.
Daicel is headquartered in Minato, Japan. It is registered at Minato, Tokyo, Japan.
Misao Fudaba is the current CEO of Daicel.
Annual revenue of Daicel is $3.93B as on Mar 31, 2025.
Daicel was established in 1919 in Minato City, Japan, as a key player in the chemical sector. Operations encompass the manufacture and distribution of various organic and cellulose-based chemicals for industrial applications. Products are supplied to sectors including pharmaceuticals, electronics, and automotive industries. Headquarters remain in Japan, with global reach through international partnerships and exports. Leadership is provided by CEO Misao Fudaba.
Daicel has made 3 acquisitions, including Arbor Biosciences, Lomapharm, and Special Devices.